MENU
In this issue

Cover Focus

Genetic Testing in Neuromuscular Disorders image

Genetic Testing in Neuromuscular Disorders

Understanding ordering and interpretation of genetic tests is paramount for clinical management.

James P. Orengo, MD, PhD; and David R. Murdock, MD

HyperCKemia image
TOP

HyperCKemia

Evaluation for elevated creatine kinase is a required skill for neurologists.

Nicholas J. Silvestri, MD; and Gil I. Wolfe, MD

Utility of Skin Biopsy in Neuromuscular Disease image
TOP

Utility of Skin Biopsy in Neuromuscular Disease

Intraepidermal nerve fiber density finding can help diagnose small fiber neuropathy.

David S. Saperstein, MD

Amyotrophic Lateral Sclerosis image
TOP

Amyotrophic Lateral Sclerosis

Integrated care provides the best quality of life.

Jonathan R. Brent, MD, PhD; and Senda Ajroud-Driss, MD

July/August 2019 teaser

Myasthenia Gravis Treatment

Both symptomatic and maintenance treatments are available.

Thy Nguyen, MD; and Cecile L. Phan, MD

Spinal Muscular Atrophy image

Spinal Muscular Atrophy

A devastating disease now has 2 approved breakthrough treatments available.

Wijdan Rai, MD; and Bakri Elsheikh, MBBS

Congenital Myasthenic Syndrome Treatment image

Congenital Myasthenic Syndrome Treatment

Heterogeneity makes diagnosis and treatment challenging.

Stanley Jones P. Iyadurai, MD, PhD, FAAN

July/August 2019 teaser

Sporadic Inclusion Body Myositis

An update on pathophysiology with diagnostic and treatment implications.

Matthew Varon, MD; and Pedro M. Machado, MD, PhD

Noninflammatory Myopathies image

Noninflammatory Myopathies

As genetic diagnosis increases, noninflammatory myopathies are being seen more in clinical practice.

Yessar Hussain, MD; Krishna Pokala, MD; and Nancy Kuo, MS, MD

Differential Diagnosis of Distal Myopathies image

Differential Diagnosis of Distal Myopathies

The era of clinical molecular genetics has refined diagnosis and will hopefully lead to disease-modifying treatments.

Kevin J. Felice, DO

Muscle Cramps image
TOP

Muscle Cramps

Reliable and validated outcome measures and new treatments are needed.

Hans D. Katzberg, MD, MSc, FRCPC; and Hamid Sadeghian, MD, FRCPC

Read Issue